FSD Pharma (TSE:HUGE) has released an update.
FSD Pharma Inc. has announced the filing of an amended and restated material change report to provide additional details regarding its recent private placement of Class A Multiple Voting Shares. The updated document includes enhanced disclosure on the offering’s purpose, anticipated impact on the company, and the board approval process. Moreover, it details the share exchange following a plan of arrangement with Celly Nutrition Corp, affecting the company’s share structure and individual holdings.
For further insights into TSE:HUGE stock, check out TipRanks’ Stock Analysis page.
